EUVIMEDEUVIMED entdecken
Leserbrief

Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate

Shanbing Wang, Jiapei Liu, Fang Xie

New England Journal of Medicine · 16.04.2026 · 394 (15) · 1548-1549

DOI: 10.1056/nejmc2518316 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 16.04.2026. Verfasst von Shanbing Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Second People's Hospital of Yibin, Yibin, China. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Second People's Hospital of Yibin, Yibin, China.

Zitieren

APA

Wang, S., Liu, J., & Xie, F. (2026). Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate. New England Journal of Medicine, 394(15), 1548-1549. https://doi.org/10.1056/nejmc2518316

Vancouver

Wang S, Liu J, Xie F. Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate. New England Journal of Medicine. 2026;394(15):1548-1549. doi:10.1056/nejmc2518316

BibTeX
@article{Wang2026,
  author = {Wang, Shanbing and Liu, Jiapei and Xie, Fang},
  title = {Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {15},
  pages = {1548--1549},
  doi = {10.1056/nejmc2518316}
}
Kostenlos starten →